Working... Menu

Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) as Add-on to Ezetimibe Therapy in Patients With Elevated LDL-C (CLEAR Tranquility)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03001076
Recruitment Status : Completed
First Posted : December 22, 2016
Last Update Posted : March 29, 2019
Information provided by (Responsible Party):
Esperion Therapeutics

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 11, 2018
  Actual Study Completion Date : February 12, 2018
  Certification/Extension First Submitted : September 21, 2018
Publications of Results:
Other Publications: